SN

Shenbagalinga Nadar Rajendran

Active Director Director DIN 01645466
DIN 01645466 First appointment Mar 1994 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Mar 1994
Shareholding value •••• Premium profile

About Shenbagalinga Nadar Rajendran

Data last updated:

Shenbagalinga Nadar Rajendran is a Director at Shenbagam Hospitals Private Limited (since 1999), Director at Indian Mri Diagnostic & Research Limited (since 1995) and Director at Shenbagam Diabetes Clinic Private Limited (since 2016), and holds 2 more current directorships. The companies operate in Healthcare, Appreal & Fashion and Service. The 5 current companies with reported revenue have a combined latest revenue of ₹19.18 Cr; the largest is Shenbagam Hospitals Private Limited at ₹9.03 Cr (FY 2024).

DIN 01645466
Primary Designation Director
Industry Healthcare
First Appointment 01 Mar 1994
Oldest Company Age 107 yrs
Largest company Shenbagam Hospitals Private Limited · ₹9.03 Cr (FY 2024)
Combined revenue ₹19.18 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shenbagam Hospitals Private Limited U85110TN1999PTC042128
Director23 Mar 19991999₹9.03 Cr (FY 2024)Active
Director28 Jun 19951986₹6.02 Cr (FY 2024)Active
Director01 Mar 20162016₹2.21 Cr (FY 2024)Active
M.A.C.S. Textiles Private Limited U74900TN1994PTC026906
Director01 Mar 19941994₹1.52 Cr (FY 2025)Active
Director17 Aug 20181919₹39.1 Lakh (FY 2022)Active

Directorship timeline

Open interactive timeline →
M.A.C.S. Textiles Private Limited
Indian Mri Diagnostic & Research Limited
Shenbagam Hospitals Private Limited
Shenbagam Diabetes Clinic Private Limited
Premium access

Shareholding and investment profile for Shenbagalinga Nadar Rajendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shenbagalinga Nadar Rajendran

Shenbagalinga Nadar Rajendran currently holds 5 directorships: Shenbagam Hospitals Private Limited (Director, since 23 Mar 1999, revenue ₹9.03 Cr (FY 2024)); Indian Mri Diagnostic & Research Limited (Director, since 28 Jun 1995, revenue ₹6.02 Cr (FY 2024)); Shenbagam Diabetes Clinic Private Limited (Director, since 01 Mar 2016, revenue ₹2.21 Cr (FY 2024)); M.A.C.S. Textiles Private Limited (Director, since 01 Mar 1994, revenue ₹1.52 Cr (FY 2025)); Sattur Hindu Nadars' Edward School Committee (Director, since 17 Aug 2018, revenue ₹39.1 Lakh (FY 2022)).

Shenbagalinga Nadar Rajendran was first appointed on 01 Mar 1994 as Director at M.A.C.S. Textiles Private Limited. The most recent appointment on record is 17 Aug 2018 at Sattur Hindu Nadars' Edward School Committee.

The 5 current companies of Shenbagalinga Nadar Rajendran that report revenue have a combined latest revenue of ₹19.18 Cr: Shenbagam Hospitals Private Limited ₹9.03 Cr (FY 2024); Indian Mri Diagnostic & Research Limited ₹6.02 Cr (FY 2024); Shenbagam Diabetes Clinic Private Limited ₹2.21 Cr (FY 2024); M.A.C.S. Textiles Private Limited ₹1.52 Cr (FY 2025); Sattur Hindu Nadars' Edward School Committee ₹39.1 Lakh (FY 2022).

The current boards of Shenbagalinga Nadar Rajendran's companies include Muthiaayyakutychidambaram Shenbagalingam Rajendran Surendran (Shenbagam Hospitals Private Limited), Surendran Rohini (Shenbagam Hospitals Private Limited), Guru Nadar Baskar (Indian Mri Diagnostic & Research Limited), Jayapalan Jegan (Indian Mri Diagnostic & Research Limited), Muthiah Alagappan (Indian Mri Diagnostic & Research Limited), Muthiah Srinivasan (Indian Mri Diagnostic & Research Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available